Kechuang ban evening news | European Commission announces energy plan to double Cecep Solar Energy Co.Ltd(000591) photovoltaic power generation capacity by 2025

The main contents of today’s Kechuang board evening news are: covid-19 small molecule drug vv116 was released in the first clinical study of Omicron infected subjects in China Do-Fluoride New Materials Co.Ltd(002407) officially entered TSMC’s qualified supplier system.

[hotspot Focus]

National Energy Administration: by the end of April, the installed capacity of power generation in China was about 2.41 billion kw, with a year-on-year increase of 7.9%

According to the data of the national energy administration, as of the end of April, the installed capacity of power generation in China was about 2.41 billion kw, a year-on-year increase of 7.9%. Among them, the installed capacity of wind power was about 340 million KW, a year-on-year increase of 17.7% Cecep Solar Energy Co.Ltd(000591) installed power generation capacity was about 320 million KW, an increase of 23.6% year-on-year. From January to April, the cumulative average utilization of power generation equipment in China was 1176 hours, a decrease of 41 hours over the same period last year. Among them, 1417 hours of thermal power, 51 hours less than the same period last year; 2447 hours of nuclear power, a decrease of 4 hours over the same period last year; 778 hours of wind power, 45 hours less than the same period last year. From January to April, the investment in power supply projects of major power generation enterprises in China was 117.3 billion yuan, a year-on-year increase of 5.1%. Among them, Cecep Solar Energy Co.Ltd(000591) power generation was 29 billion yuan, an increase of 204.1% year-on-year. The investment in power grid projects was 89.3 billion yuan, a year-on-year increase of 4.7%.

European Commission announces energy plan to double Cecep Solar Energy Co.Ltd(000591) photovoltaic power generation capacity by 2025

The European Commission announced an energy plan called “repowereu” on the 18th to quickly promote the transformation of green energy. The plan proposes to increase the overall target of renewable energy in 2030 in the EU’s “55% carbon reduction” policy portfolio from 40% to 45%; Establish a special EU Cecep Solar Energy Co.Ltd(000591) strategy to double Cecep Solar Energy Co.Ltd(000591) photovoltaic power generation capacity by 2025 and install 600gw by 2030; Double the deployment rate of heat pumps and take measures to integrate geothermal and Cecep Solar Energy Co.Ltd(000591) into modern regional and public heating systems; By 2030, 10 million tons of renewable hydrogen will be produced and 10 million tons will be imported to replace natural gas, coal and oil used by industries and transportation sectors that are difficult to reduce carbon. The European Commission also announced that the EU Cohesion Fund and the common agricultural policy (CAP) can provide 26.9 billion euros and 7.5 billion euros to the EU recovery measures Fund (RRF) through voluntary transfer. The European Commission will double the large-scale collection of funds from the innovation fund in 2022 to about 3 billion euros this autumn.

anti covid-19 virus small molecule oral drug vv116 released in the first clinical study of Omicron infected subjects in China

According to the “Huashan infection” news, the anti covid-19 virus small molecule oral drug vv116 was released in the first clinical study of Omicron infected subjects in China. Vv116 is an oral small molecule anti covid-19 virus drug developed by Chinese scientists. Relevant results were published in the journal emerging microbes & infections on May 18. The data showed that the nucleic acid negative time of patients infected with Omicron using vv116 within 5 days after the first positive nucleic acid test was 8.56 days, which was less than 11.13 days in the control group. In symptomatic patients, vv116 given within the medication time range of this study (2-10 days after the first nucleic acid positive) can shorten the nucleic acid negative time of patients. In terms of drug safety, no serious adverse reactions were observed in patients who used vv116. The sample size included in the study was limited, and all subjects did not develop severe or critical illness. This is the first peer-reviewed report on the clinical research results of “domestic” anti covid-19 virus drugs on Omicron infected people.

Do-Fluoride New Materials Co.Ltd(002407) : the company has officially entered TSMC’s qualified supplier system

Do-Fluoride New Materials Co.Ltd(002407) announced that the company has officially entered the qualified supplier system of TSMC and recently began to deliver high-purity electronic chemical materials to TSMC (Nanjing) Co., Ltd.

depth:

A new round of lithium competition started: the latest bidding of snowway mining auction exceeded 400 million yuan, and more than 500000 people “eat melons online”

260 billion yuan! The backlog of orders of automobile chip leaders is three times that of revenue, and only 75% can be delivered within one year

All silicon negative battery is coming! The highest energy density increased by 40%. Which negative electrode companies are ahead in the progress of “silicon doping”?

[announcement of science and innovation board]

Bestechnic (Shanghai) Co.Ltd(688608) : it is proposed to repurchase shares with RMB 48 million-96 million

Bestechnic (Shanghai) Co.Ltd(688608) announced that it is planned to repurchase shares with 48 million yuan to 96 million yuan, the repurchase price shall not exceed 160 yuan / share, and the source of repurchase funds is the over raised funds of the company. Based on the company’s current total share capital of 120 million shares, the proportion of repurchased shares accounts for 0.25% – 0.5% of the company’s total share capital.

Bonree Data Technology Co.Ltd(688229) : it is proposed to repurchase shares of the company ranging from 30 million yuan to 60 million yuan

Bonree Data Technology Co.Ltd(688229) announced that the total amount of funds to be repurchased shall not be less than 30 million yuan and not more than 60 million yuan; The repurchase price shall not exceed 60 yuan / share (inclusive). All the repurchased shares will be used for the employee stock ownership plan and transferred within three years after the completion of the repurchase; If the company fails to transfer the repurchased shares within three years after the implementation result of share repurchase and the announcement date of share change, the unused repurchased shares will be cancelled.

Suzhou Uigreen Micro&Nano Technologies Co.Ltd(688661) : Director Ma Hongwei plans to increase his holding of shares by RMB 10-20 million

Suzhou Uigreen Micro&Nano Technologies Co.Ltd(688661) announced that Ma Hongwei, the director of the company, plans to increase the shares of the company in the way allowed by the trading system of Shanghai Stock Exchange within 12 months from May 19, 2022, with a total increase of no less than 10 million yuan and no more than 20 million yuan.

Suzhou Iron Technology Co.Ltd(688329) : the shareholder Wen Qingnan plans to reduce his shares by no more than 3%

Suzhou Iron Technology Co.Ltd(688329) announced that due to the capital needs of shareholders, Wen Qingnan, the shareholder of the company, plans to reduce his total shares of the company by means of centralized bidding and block trading, with a reduction ratio of no more than 3% of the total shares of the company.

[issuance and approval status]

municipal Party Committee on the science and Innovation Board: San Wei Xin’an and golden orange will start the meeting on May 25

The Listing Committee of the science and innovation board is scheduled to hold a review meeting on May 25 to review the initial issues of Sanwei Xinan Technology Co., Ltd. and Beijing Golden Orange Technology Co., Ltd 3 companies’ review status update

As of press time, a total of 724 companies’ applications for listing on the science and innovation board have been accepted, and the issuance and approval status of 3 companies has been updated.

Among them, Sanwei Xinan, golden orange and British software have been inquired.

[venture capital weathervane]

Kejie technology has completed a round of financing of hundreds of millions of yuan and is committed to the independent and controllable big data base

Beijing Kejie Technology Co., Ltd. announced the previously completed round a financing of RMB 100 million. This round of financing was led by Huaye Tiancheng capital and xvc, followed by size capital, and continued to be filled by koala fund, an old shareholder. It is reported that the financing will be used for the R & D and upgrading of domestic big data base product matrix, and build a comprehensive data capability methodology to help large organizations complete independent and controllable data capability construction and promote the digital transformation process of various industries with leading technical products and best practices.

Wudun safely completed tens of millions of yuan pre-A round of financing

Wudun security has completed the pre-A round of financing of tens of millions of yuan. This round of financing is led by Qi’an investment and followed by the old shareholder Yuandu venture capital. After this round of financing, it will continue to expand its investment in R & D, operation and marketing team, increase the construction of safety protection system, and speed up the optimization and upgrading of product schemes.

- Advertisment -